Aktie 688076 JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Aktien

688076

CNE1000051X5

688076

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 21.06.2024 		% 5 Tage % 1. Jan.
76.9 CNY +5.63% Intraday Chart für Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. +25.24% +71.08%
22.04. Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI
23.02. Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Certain A Shares of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-MAY-2024.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Sinopep-Allsino Biopharmaceutical's Raw Drug Material Gets OK to Submit Drug Application to US FDA; Shares Up 4%
Sinopep-Allsino Biopharmaceutical Gets Nod to Issue Convertible Bonds
Sinopep-Allsino’s Hypertension Drug Shortlisted for China’s Drug Procurement Program
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(XSSC:688076) added to S&P Global BMI Index
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Jiande Xinglian Enterprise Management Co., Ltd. entered into an agreement to acquire 4.84% in Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. from Jiande Wuxing Biological Technology Co., Ltd. for CNY 369 million.
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 300 million in funding
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Sinopep-Allsino Biopharma Unit to Buy 9% Stake in Biotech Firm
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Zhejiang Zhongcheng Pharmaceutical Co., Ltd. agreed to acquire 45% stake in Hangzhou Xinbosi Biopharmaceutical Co., Ltd. from Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. for CNY 13.5 million.
Certain A Shares of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-MAY-2022.
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(SHSE:688076) added to Shanghai Stock Exchange Composite Index
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(SHSE:688076) added to Shanghai Stock Exchange A Share Index
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 688076 Aktie
  4. Nachrichten Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
  5. Andere Sprachen